Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T15:13:04.613Z.
Calculation as of: 2026-10-06T15:13:04.613Z.
Quote observation: 2026-10-06T15:09:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f522eee919378f7ead273ce64f9b652ac6d8ba1380de8c5eb79fdcf7ed4dc2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$30.66M
PS Ratio
191.25
TTM Avg
248.61
3Y Avg
248.61
5Y Avg
248.61
Market Cap
$31.36M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.82M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | N/A | 74.19 | 53.76 | 254.70 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.06M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $30.66M | 191.25 | 248.61 | 248.61 | 248.61 |
| Context Therapeutics Inc. (CNTX)vs › | $31.85M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.04M | 93.14 | 131.68 | 131.68 | 131.68 |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 0.25 | 0.27 | 0.24 | 0.25 |
| OneMedNet Corporation (ONMD)vs › | $29.42M | 20.20 | 65.83 | 42.42 | 57.23 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | 2.79 | 7.06 | 18.39 | 15.88 |
Half-year reporter: no trailing two-half-year basis, because the half-year figures do not reconcile with the annual report: the newest completed fiscal year's two halves differ from its annual revenue or net income by more than 5%.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
